Trichinella spiralis infection remodels intestinal neurotransmitter metabolism during LPS-induced systemic inflammation Authors: Ruohang Sun, Yi Liu, Qingbo Lv, Kaimeng Shang, Nuo Xu, Mingfei Sun, Mingyuan Liu, Zhuangzhi Zhang, Xiaolei Liu, Xuemin Jin Published: 2026 ABSTRACT Parasitic helminths can modulate host inflammatory responses, but whether this regulation involves remodeling of the intestinal neurochemical environment remains unclear. Here, we investigated whether Trichinella spiralis infection alters intestinal neurotransmitter-related metabolism during lipopolysaccharide (LPS)-induced systemic inflammation. In this study, we established an LPS-induced inflammatory model and a T. spiralis-infection with LPS challenge model. At 14 days after infection, mice were challenged with LPS, and inflammatory responses and duodenal neurotransmitter-related metabolites were assessed. T. spiralis infection reduced serum TNF-α and IL-1β levels and alleviated LPS-induced lung pathology. Targeted LC–MS/MS profiling revealed treatment-specific neurochemical signatures in duodenal tissues. Under basal conditions, T. spiralis infection increased histamine levels and reduced norepinephrine, 5-hydroxyindoleacetic acid, and xanthurenic acid. During LPS challenge, prior T. spiralis infection was associated with increased dopamine, epinephrine, levodopa, 5-hydroxytryptophan, histamine, and tyramine compared with LPS challenge alone. These changes suggest that T. spiralis infection remodels tyrosine-, histidine-, and tryptophan-related neurochemical pathways in the intestine. Receiver operating characteristic analysis further identified several metabolites that discriminated LPS-challenged mice from T. spiralis-infected, LPS-challenged mice, although these candidate signatures require validation in larger independent cohorts. Together, our findings indicate that intestinal neurochemical remodeling may represent a previously underappreciated component of helminth-associated anti-inflammatory regulation. Introduction Parasitic helminths are structurally complex multicellular eukaryotes with long life cycles, capable of establishing long-term and finely tuned interactions with their hosts (Wells and Flynn, 2022). While helminth infections remain a significant global public health burden, often leading to malnutrition and tissue damage (Badri et al., 2025; Hotez et al., 2008; Torgerson et al., 2015), epidemiological evidence supporting the “hygiene hypothesis” reveals a paradox: the eradication of helminths in modern societies correlates with a marked rise in autoimmune and allergic disorders. Studies have shown that immune alterations induced by helminth exposure can ameliorate immune-mediated diseases, including asthma, multiple sclerosis, and inflammatory bowel disease (Maizels, 2016; Versini et al., 2015; Zhang and Gems, 2021). These observations suggest that helminths, as ancient co-evolutionary partners, play a critical role in training the host immune system and maintaining immune homeostasis (Little et al., 2010; Maizels and Mcsorley, 2016). As high-energy-demand multicellular parasites, helminths rely heavily on host-derived nutrients, establishing a tight link with host metabolism (Sun et al., 2024). Previous studies have demonstrated that helminth infections can profoundly remodel host amino acid, lipid, and carbohydrate metabolism, as well as bile acid circulation (Cortes-Selva and Fairfax, 2021; Kennedy et al., 2021; Lane et al., 2023). Furthermore, helminths may indirectly influence host metabolism by modulating the gut microbiota—for example, by promoting the expansion of Lactobacillus and Bifidobacterium species and regulating short-chain fatty acid production (Kennedy et al., 2021; Zaiss et al., 2015). However, these metabolic shifts are increasingly recognized not merely as nutritional adaptations, but as a strategic manipulation of signaling molecules. This is particularly relevant in the intestine, the primary target organ of infection, which serves as a central hub for both metabolic and neuroregulatory processes. Often referred to as the “second brain,” the intestine harbors the enteric nervous system (ENS), a complex network of millions of neurons (Avetisyan et al., 2015; Schneider et al., 2019). The ENS precisely regulates intestinal motility, secretion, and mucosal barrier integrity through the synthesis and release of various neurotransmitters, such as serotonin, acetylcholine (ACh), γ-aminobutyric acid (GABA), and dopamine (DA) (Wang et al., 2024). Crucially, these neurochemical messengers are downstream products of the very metabolic pathways (e.g., tryptophan and tyrosine metabolism) that helminths are known to reprogram. While recent evidence suggests that helminth infections can modulate host responses by reshaping the neurotransmitter network (Lu and Jackson, 2025; Wang et al., 2018), the specific mechanisms by which Trichinella spiralis—a parasite well-known for its immunomodulatory capabilities—alters the intestinal neurochemical landscape remain poorly understood. In this study, we hypothesized that the immune responses induced by T. spiralis infection during the intestinal phase could alleviate LPS-induced inflammation and that T. spiralis infection actively reshapes the host intestinal neurotransmitter profile to create a protective “neuro-metabolic interface”. To test this hypothesis, we established an LPS-induced inflammatory model and evaluated the protective effects of T. spiralis infection. Histopathological examination of lung tissues revealed that T. spiralis infection during the intestinal phase effectively attenuated LPS-induced acute lung injury, while serum cytokine analysis demonstrated that T. spiralis infection suppressed the LPS-induced cytokine storm. To further investigate the neurochemical basis underlying these protective effects, we employed targeted neurotransmitter metabolomics based on LC–MS/MS to analyze intestinal tissues from mice under both homeostatic and LPS-induced inflammatory conditions. Our results reveal that T. spiralis infection during the intestinal phase significantly reprograms intestinal neurotransmitter metabolism, particularly involving pathways related to histamine (HisA), tyramine (TyrA), DA, epinephrine (E), and tryptophan metabolism. These findings highlight a sophisticated strategy by which helminths may hijack host neuro-immune signaling to mitigate inflammatory damage, thereby exerting potent immunomodulatory and anti-inflammatory effects. Materials and methods Helminth infection Muscle larvae (ML) of T. spiralis (ISS534) were isolated from Wistar rats 35 days after oral administration of 5000 infective larvae. To establish a helminth infection model, six-week-old male C57BL/6 J wild-type (WT) mice (obtained from Changchun Yisi Biotechnology Co., Ltd. (China)) were orally inoculated with 250 TsML. The animals were maintained on a standard rodent diet with free access to water and kept under a 12-h light/dark cycle throughout the experiment. Duodenal tissues were collected following euthanasia by CO₂ exposure at 14 days post-infection (dpi). LPS experiments in mice LPS from Escherichia coli O111: B4 (L2630, Sigma-Aldrich) was prepared as a 1 mg/mL solution in sterile, pyrogen-free PBS and stored at −20 °C. Male C57BL/6 J mice were randomly assigned to four groups: control (Con, n = 3), T. spiralis-infected (n = 6), LPS-treated (n = 8), and T. spiralis-infected followed by LPS treatment (T. spiralis_LPS, n = 6). Samples were collected 6 h after LPS injection. Histology evaluation Lung tissues were promptly collected and fixed in 4% paraformaldehyde for at least 24 h, followed by paraffin embedding. Paraffin sections (5 μm) were subsequently prepared and stained with hematoxylin and eosin (H&E) for histopathological examination under a light microscope. Lung injury severity was evaluated based on four histopathological parameters, including pulmonary hemorrhage, alveolar congestion, and neutrophil infiltration in the vascular wall or alveolar space. Each parameter was scored on a scale of 0–4, where 0 represented minimal injury, 1 mild injury, 2 moderate injury, 3 severe injury, and 4 maximal injury. The total lung injury score was calculated as the sum of all individual scores. Serum cytokine measurement by ELISA Blood samples were collected from the retro-orbital plexus of mice and centrifuged at 3000 rpm for 15 min at 4 °C to separate serum, Serum levels of the pro-inflammatory cytokines TNF-α and IL-1β (Elabscience, Wuhan, China) were quantified using commercially available mouse ELISA kits according to the manufacturer's instructions. Targeted quantification of neurotransmitter metabolites Targeted metabolomic analysis of neurotransmitter metabolites was performed by Novogene. Co., Ltd. using targeted metabolomics. All standards, including stable isotope-labeled analogs, were sourced from ZZStandards Co., LTD. Methanol (Optima LC-MS), acetonitrile (Optima LC-MS), formic acid (Optima LC-MS) and ammonium acetate (Optima LC-MS) were purchased from Thermo-Fisher Scientific. Imino-bis (methylphosphonic acid) was purchased from Sigma-Aldrich. Ultrapure water was purchased from Millipore. In brief, the stock solution of individual central carbon metabolism (CCM)-related compounds was mixed and prepared in CCM-related compounds-free matrix to obtain a series of calibrators. The samples were pulverized in liquid nitrogen and subsequently resuspended in water by thorough vortexing to obtain diluted samples. An aliquot of 100 μL from each diluted sample was then mixed with 300 μL of 80% methanol containing a mixture of internal standards and vortexed thoroughly. The samples were incubated for 10 min and subsequently centrifuged at 15,000 ×g for 15 min. The resulting supernatants were collected and injected into the LC-MS/MS system for analysis. Metabolite identification and data analysis Metabolite abundance data were log-transformed and Pareto-scaled prior to partial least squares discriminant analysis (PLS-DA) to improve comparability across samples. Differential metabolite patterns were visualized with heatmaps using the pheatmap package in R (v4.2.1). Hierarchical clustering was performed based on the Bray–Curtis distance and complete linkage method. The receiver operating characteristic (ROC) curve was generated to evaluate the sensitivity and specificity of each metabolite as a marker. The area under the ROC curve (AUC) was calculated for each experimental group and the control group, and a metabolite was indicated to have high diagnostic performance when the AUC was ≥0.85. Statistical analysis GraphPad Prism (version 8.0) was used for statistical analyses and graphical representations. For comparisons across three or more groups, analysis of variance (ANOVA) was performed. Statistical significance in metabolomics and metagenomic analysis was determined by analysis of the FDR by the Benjamini-Hochberg method. Statistical significance was set at p < 0.05. Results T. spiralis infection protects against LPS-induced systemic inflammation To investigate the regulatory effects of T. spiralis infection on systemic inflammatory responses, a mouse model of systemic inflammation was established via intraperitoneal injection of LPS. Serum ELISA results demonstrated that LPS-induced sepsis significantly elevated the levels of pro-inflammatory cytokines TNF-α and IL-1β in mice, whereas T. spiralis infection markedly reduced the expression of these cytokines (Fig. 1A and B). Given the high vascularization and extensive microvascular network of the lung, circulating LPS and LPS-induced inflammatory mediators are prone to accumulate in pulmonary tissue, making the lung one of the earliest and most severely affected target organs during systemic inflammatory responses. Therefore, lung tissues were further subjected to histopathological analysis by H&E staining. Histological results showed that mice in the LPS group exhibited severe pulmonary injury, characterized by disrupted alveolar architecture, diffuse interstitial edema, and extensive inflammatory cell infiltration (Fig. 1C and D). In contrast, these pathological alterations were significantly alleviated in the T. spiralis-pretreated group, accompanied by a markedly reduced lung injury score.Fig. 1Protective effect of T. spiralis infection on LPS-induced systemic inflammation.(A and B) The levels of the serum cytokines TNF-α (A) and IL-1β (B).(C) Lungs from each experimental group were processed for histological evaluation.(D) Histopathological damage scores were determined for the lung tissue samples.n = 3–8 mice per group. **** p < 0.0001 as indicated by the line. (one-way ANOVA with Tukey's post-test).Fig. 1 Protective effect of T. spiralis infection on LPS-induced systemic inflammation. (A and B) The levels of the serum cytokines TNF-α (A) and IL-1β (B). (C) Lungs from each experimental group were processed for histological evaluation. (D) Histopathological damage scores were determined for the lung tissue samples. n = 3–8 mice per group. **** p < 0.0001 as indicated by the line. (one-way ANOVA with Tukey's post-test). PLS-DA reveals distinct neurotransmitter metabolic profiles To further investigate the impact of T. spiralis infection during the intestinal stage on the composition and function of host neurochemical mediators, we performed targeted neurotransmitter metabolomic profiling of intestinal tissues from infected mice using LC–MS/MS. To comprehensively analyze the metabolic differences among treatment groups, we applied PLS-DA, a commonly used supervised multivariate statistical method in metabolomics that identifies discriminative metabolic features by maximizing intergroup variation. The PLS-DA results revealed that samples from the Con, LPS, T. spiralis, and T. spiralis_LPS groups formed distinct and clearly separated clusters, indicating that different treatments induced significant metabolic heterogeneity. The first and second principal components explained 26.2% and 15.8% of the total variance, respectively, reflecting the major sources of metabolic variation in the dataset (Fig. 2A and B).Fig. 2Multivariate analysis of sample clustering based on metabolic profiles.(A) Partial least squares discriminant analysis (PLS-DA) score plot showing group separation among Con, T. spiralis, LPS, and T. spiralis_LPS groups. Each point represents an individual sample, and the ellipses indicate the 95% confidence interval for each group. The percentage of variance explained by each component is indicated on the corresponding axis.(B) Three-dimensional PLS-DA score plot based on Comp 1, Comp 2, and Comp 3, further illustrating the spatial distribution and discrimination of the four experimental groups. Clear separation among groups reflects distinct metabolic patterns induced by different treatments.Fig. 2 Multivariate analysis of sample clustering based on metabolic profiles. (A) Partial least squares discriminant analysis (PLS-DA) score plot showing group separation among Con, T. spiralis, LPS, and T. spiralis_LPS groups. Each point represents an individual sample, and the ellipses indicate the 95% confidence interval for each group. The percentage of variance explained by each component is indicated on the corresponding axis. (B) Three-dimensional PLS-DA score plot based on Comp 1, Comp 2, and Comp 3, further illustrating the spatial distribution and discrimination of the four experimental groups. Clear separation among groups reflects distinct metabolic patterns induced by different treatments. Notably, the T. spiralis_LPS group was clearly separated from the other three groups along Component 1, indicating that the combined treatment induced a metabolomic reprogramming pattern distinct from that triggered by individual treatments. Similarly, the T. spiralis and LPS groups were also well separated from the control group and from each other, reflecting pronounced metabolic remodeling induced by inflammatory stimulation and T. spiralis intervention, respectively. These findings suggest that different treatments can drive distinct metabolic phenotypes, providing important clues for further elucidating key metabolic pathways and their roles in biological responses. T. spiralis infection differentially modulates intestinal neurotransmitter metabolism To systematically elucidate the regulatory effects of T. spiralis infection on host intestinal neurotransmitters, we performed metabolic profiling across the four treatment groups and visualized the results using hierarchical clustering heatmaps and quantitative box plots. A total of 16 neurotransmitters was detected, and heatmap analysis revealed a distinct clustering pattern in the overall neurotransmitter profile among different groups (Fig. 3). Quantitative analysis of individual neurotransmitters using box plots revealed distinct neurochemical alterations following T. spiralis infection. Under homeostasis conditions, the level of the immunomodulatory neurotransmitter HisA was significantly elevated in the infected group compared with the control, whereas the concentrations of norepinephrine (NE), 5-hydroxyindoleacetic acid (5-HIAA), and xanthurenic acid (XA) were markedly reduced. These metabolic shifts indicate that T. spiralis infection remodels the composition of host intestinal neurotransmitters. Helminths can alter the composition of the host gut microbiota and modulate immune status, and our findings suggest that enteric neural signaling may play a key role in mediating these host–parasite interactions.Fig. 3Heatmap of differentially abundant metabolites among the four groups.Heatmap showing the relative abundance of neurotransmitters and amino acid–derived metabolites in the Con, T. spiralis, LPS, and T. spiralis_LPS groups. Colors indicate relative metabolite levels (red, higher abundance; blue, lower abundance), highlighting distinct metabolite distribution patterns among different treatments. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3 Heatmap of differentially abundant metabolites among the four groups. Heatmap showing the relative abundance of neurotransmitters and amino acid–derived metabolites in the Con, T. spiralis, LPS, and T. spiralis_LPS groups. Colors indicate relative metabolite levels (red, higher abundance; blue, lower abundance), highlighting distinct metabolite distribution patterns among different treatments. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Under LPS-induced inflammatory conditions, T. spiralis treatment markedly altered the host neurochemical profile, characterized by significant upregulation of DA, E, levodopa (DOPA), 5-hydroxytryptophan (5-HTP), HisA, and TyrA levels (Fig. 4A-P).Fig. 4Differential neurotransmitter profiles among experimental groups.(A-P) Box plots showing the relative intensities of neurotransmitters and related metabolites in the Con, T. spiralis, LPS, and T. spiralis_LPS groups. Metabolites analyzed include (A) GABA, (B) HisA, (C) TyrA, (D) Ach, (E) DA, (F) NE, (G) tyrosine (Tyr), (H) E, (I) 5-HIAA, (J) DOPA, (K) tryptophan (Trp), (L) XA, (M) kynurenine (Kyn), (N) 5-HTP, (O) melatonin (MT), and (P) His. Each dot represents an individual sample. Data are presented as median with interquartile range. Statistical significance between groups is indicated by asterisks (*p < 0.05, **p < 0.01, ***p < 0.001).Fig. 4 Differential neurotransmitter profiles among experimental groups. (A-P) Box plots showing the relative intensities of neurotransmitters and related metabolites in the Con, T. spiralis, LPS, and T. spiralis_LPS groups. Metabolites analyzed include (A) GABA, (B) HisA, (C) TyrA, (D) Ach, (E) DA, (F) NE, (G) tyrosine (Tyr), (H) E, (I) 5-HIAA, (J) DOPA, (K) tryptophan (Trp), (L) XA, (M) kynurenine (Kyn), (N) 5-HTP, (O) melatonin (MT), and (P) His. Each dot represents an individual sample. Data are presented as median with interquartile range. Statistical significance between groups is indicated by asterisks (*p < 0.05, **p < 0.01, ***p < 0.001). Discriminative neurotransmitter signatures identified by ROC analysis To further evaluate whether the neurotransmitter alterations induced by T. spiralis infection could reliably distinguish inflammatory from parasite-modulated inflammatory states, we performed ROC curve analysis for 16 key neurotransmitters comparing the LPS and T. spiralis_LPS groups. ROC analysis assesses the diagnostic performance of individual metabolites by quantifying their ability to correctly classify samples, with the AUC providing a measure of discriminatory accuracy (AUC = 0.5 indicates no discrimination, whereas AUC = 1.0 indicates perfect discrimination). Most neurotransmitters exhibited good discriminatory performance, with AUC values exceeding 0.7, indicating that their abundance differed sufficiently between the two groups to allow reliable classification. Notably, GABA, HisA, TyrA, DA, Tyr, E, DOPA, and 5-HTP achieved AUC values greater than 0.85, demonstrating high sensitivity and specificity for distinguishing LPS-induced inflammation from T. spiralis-modulated inflammation. (Fig. 5A-P). These findings suggest that neurotransmitter remodeling induced by T. spiralis infection generates a distinct neurochemical signature and identifies several metabolites as promising biomarkers for monitoring helminth-mediated immunomodulation.Fig. 5ROC analysis of potential biomarkers in the T. spiralis and T. spiralis_LPS groups.(A-P) The score was higher than the cutoff (0.85). (A) 5-HIAA, (B) 5-HTP, (C) Ach, (D) DA, (E) DOPA, (F) E, (G) GABA, (H) His, (I) NE, (J) HisA, (K) Kyn, (L) MT, (M) Trp, (N) XA, (O) Tyr, (P) TyrA. The AUC with confidence intervals (CI) is indicated in each panel. The diagonal dashed line represents the reference line of no discrimination.Fig. 5 ROC analysis of potential biomarkers in the T. spiralis and T. spiralis_LPS groups. (A-P) The score was higher than the cutoff (0.85). (A) 5-HIAA, (B) 5-HTP, (C) Ach, (D) DA, (E) DOPA, (F) E, (G) GABA, (H) His, (I) NE, (J) HisA, (K) Kyn, (L) MT, (M) Trp, (N) XA, (O) Tyr, (P) TyrA. The AUC with confidence intervals (CI) is indicated in each panel. The diagonal dashed line represents the reference line of no discrimination. Discussion The intricate and long-standing evolutionary relationship between parasitic helminths and mammalian hosts has shaped a complex interaction that extends beyond simple pathogenicity. Through coevolution, helminths have developed sophisticated strategies to modulate host signaling pathways, ensuring their own persistence while often dampening host inflammatory responses (Maizels et al., 2025). While traditional views attributed this regulation primarily to parasite-secreted immunomodulatory molecules (Hewitson et al., 2009; Maizels et al., 2018), accumulating evidence suggests that helminths also profoundly reshape host metabolic and neural networks (Sikder et al., 2024). In particular, increasing evidence has shown that intestinal neurons are capable of sensing dynamic changes in the gut microenvironment and participate in the regulation of host immune responses through the release of various immunomodulatory neuro-signaling molecules (Cardoso et al., 2017). In this study, we demonstrated that T. spiralis infection during the intestinal phase fundamentally alters the intestinal neurotransmitter landscape and profoundly reshapes the host intestinal neurochemical environment through the reprogramming of neurotransmitter metabolism. This remodeling suggests that the parasite establishes a specific neuro-metabolic interface that coordinates neuro-immune signaling and promotes host immune homeostasis. Such a mechanism may underlie the ability of intestinal-phase T. spiralis infection to attenuate LPS-induced cytokine storms and related inflammatory pathology, highlighting a previously underappreciated strategy by which helminths protect the host from excessive inflammatory damage. Under homeostatic conditions, T. spiralis infection orchestrates a delicate balance between expulsion and tolerance. We observed a significant elevation in HisA, contrasting with a remodeling of tryptophan metabolism. The surge in HisA, primarily derived from mast cells and basophils, aligns with the classical Th2-type immune response. Elevated HisA promotes mucus secretion and intestinal motility, serving as an expulsion signal to limit parasite burden. Concurrently, the metabolic flux of tryptophan appears to be redirected. The observed reduction in serotonin (5-HIAA) and kynurenine metabolites (XA), coupled with preserved tryptophan levels, suggests a shift towards the microbiota-mediated indole pathway. T. spiralis infection is known to enrich Lactobacillus species, which convert tryptophan into indole derivatives. These indoles act as ligands for the aryl hydrocarbon receptor to promote regulatory T cell expansion and IL-10 production, thereby maintaining mucosal tolerance (Agus et al., 2018; Roager and Licht, 2018). Helminths can mediate immune homeostasis by reshaping intestinal neurotransmitter signaling pathways, which may represent one of the key mechanisms underlying their anti-inflammatory effects. The most striking alteration observed during the LPS-induced sepsis challenge was the paradoxical “Trace Amine-Catecholamine” interplay. Sepsis typically triggers a sympathetic storm, where excessive NE drives immune paralysis and organ failure via β2-adrenergic receptor signaling (Stolk et al., 2020). Our data revealed that T. spiralis infection depletes basal NE while inducing a massive surge of its structural analog, TyrA, during inflammation. While previous literature has largely relegated TyrA to the status of a mere metabolic intermediate (Pasricha and Kulkarni, 2025), we postulate that this accumulated TyrA functions as a “Biological Place-holder” or “False Neurotransmitter” (Fischer and Baldessarini, 1971). By competing with NE for uptake and storage in presynaptic vesicles, TyrA may displace the potent endogenous neurotransmitter, resulting in the release of less potent amines upon sympathetic firing and thereby dampening lethal adrenergic overdrive. Furthermore, beyond this displacement effect, TyrA is a potent agonist for the Trace Amine-Associated Receptor 1 (TAAR1), which is expressed on peripheral leukocytes (Berry et al., 2017; Nelson et al., 2007). Unlike canonical adrenergic receptors that undergo desensitization during cytokine storms, TAAR1 represents a distinct G protein-coupled receptor class that may resist this homologous desensitization (Pei et al., 2016). Thus, the T. spiralis-induced TyrA surge likely engages the TAAR1-Immune Axis to exert direct anti-inflammatory effects. Parallel to the TyrA surge, T. spiralis treatment significantly upregulated DA and its precursor DOPA in septic mice. However, the precise origin of these neurotransmitters remains a “black box” necessitating future study. To fully elucidate the mechanistic precision of this regulation and its translational potential for sepsis therapy, future studies must address the unresolved question of their origin and functional targets. First, the tripartite origin of these neurotransmitters remains to be deciphered. While we observed elevated DA and TyrA in tissue homogenates, the exact cellular source is enigmatic. This neurochemical remodeling likely stems from a complex interplay within the host-microbe-helminth ecosystem: it could arise from the host's enteric neurons or activated immune cells, the metabolic byproducts of a helminth-reshaped microbiota (e.g., Lactobacillus spp.) (Pasricha and Kulkarni, 2025), or even directly from the parasite itself, as many nematodes possess developed neural systems capable of secreting immunomodulatory molecules. Second, static concentration measurements do not reflect dynamic metabolic flux. The concomitant rise of TyrA (a precursor) and DA raises the question of whether T. spiralis accelerates DA synthesis or, alternatively, inhibits degradation enzymes such as monoamine oxidase (MAO). Distinguishing between enhanced production and blocked clearance is critical, as these represent fundamentally different pharmacological targets. Finally, the “Receptor Paradox” in clinical application must be navigated with caution. DA exerts dual effects depending on receptor subtypes—typically proinflammatory via D1-like receptors and anti-inflammatory via D2-like receptors. Although T. spiralis infection attenuates sepsis, potentially engaging the D2/TLR4 axis, determining the specific receptor subtype bias induced by the parasite is crucial. Blindly mimicking this dopaminergic surge without understanding this bias carries the risk of aggravating the cytokine storm rather than quelling it. Therefore, clarifying the contribution of these three sources and the specific receptor landscape is the key to unlocking the therapeutic potential of helminth-derived neuro-modulation. Beyond the tyrosine pathway, the remodeling of tryptophan metabolism represents a more profound strategic intervention by the parasite: the engineering of a metabolic shunt. Typically, sepsis triggers a cytokine storm (e.g., IFN-γ) that hyperactivates indoleamine 2,3-dioxygenase 1 (IDO1). This enzyme aggressively drains host tryptophan into the kynurenine pathway, leading to the accumulation of toxic metabolites and immune paralysis due to tryptophan depletion. However, our data reveal a striking “Precursor Paradox” that challenges this classical sepsis trajectory. We observed a significant reduction in downstream kynurenine metabolites, such as XA, during infection, concomitant with a massive accumulation of the serotonin precursor 5-HTP upon LPS challenge. This pattern strongly suggests that T. spiralis functions as a “metabolic dam”: it likely suppresses the host's IDO1 activity—potentially via Th2-induced cytokines—and forcefully redirects tryptophan flux towards the TPH1 pathway (Lerch et al., 2022). This creates a protective 5-HTP reservoir, serving a dual purpose beyond mere neurotransmission. First, it reverses the metabolic toxicity of sepsis by preventing the depletion of the essential amino acid tryptophan. Second, the accumulated 5-HTP likely exerts non-canonical functions. While peripheral serotonin is known to exacerbate inflammation and promote neutrophil recruitment during septic shock (Duerschmied et al., 2013), its precursor 5-HTP acts as a potent ROS scavenger to mitigate oxidative stress (Chae et al., 2009). Furthermore, as a direct precursor to melatonin—a powerful mitochondrial protector—this 5-HTP surge may be the key substrate allowing the host to maintain mitochondrial bioenergetics and prevent organ failure during sepsis (Colunga Biancatelli et al., 2020). Thus, the parasite does not merely suppress inflammation; it fundamentally rewires the host's metabolic circuitry to survive the lethal energetic demands of sepsis. Conclusion In summary, our findings demonstrate that T. spiralis actively hijacks the host's neuro-chemical interface to ensure mutual survival. By modulating specific pathways—specifically the TyrA-NE switch, dopaminergic enhancement, and the tryptophan-5-HTP shunt—the helminth effectively attenuates LPS-induced cytokine storms and the associated tissue damage. These insights not only deepen our understanding of neuro-immune crosstalk but also highlight the therapeutic potential of targeting the neuro-metabolic axis as an intervention strategy for inflammatory diseases. Mimicking these helminth-driven strategies could offer novel avenues for treating severe inflammatory diseases. CRediT authorship contribution statement Ruohang Sun: Writing – review & editing, Writing – original draft, Project administration, Investigation. Yi Liu: Project administration, Funding acquisition. Qingbo Lv: Writing – review & editing. Kaimeng Shang: Writing – review & editing. Nuo Xu: Investigation. Mingfei Sun: Investigation. Mingyuan Liu: Writing – review & editing, Funding acquisition. Zhuangzhi Zhang: Investigation. Xiaolei Liu: Funding acquisition. Xuemin Jin: Writing – original draft, Conceptualization. Ethics statement This study was conducted with approval from the Jilin University Institutional Animal Care and Use Committee (IACUC) and adhered to the university's animal welfare guidelines. Funding This study was supported by The 10.13039/501100012166National Key Research and Development Program of China (2023YFE0107300), 10.13039/501100001809National Natural Science Foundation of China (NSFC32373032,NSFC32402914), 10.13039/501100003807Science and Technology Development Planning Project of Jilin Province (20220101294JC). Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.